Efficacy and Safety of an Early Aggressive Lipid-Lowering Strategy Using Triple Therapy After Mechanical Thrombectomy.

Among 197 patients (mean age, 70.8 ± 12.1; 36.0% male), 55 received triple therapy.

Baseline total cholesterol (total cholesterol) and low-density lipoprotein cholesterol levels were comparable between groups.

At both 4 and 12 weeks, the triple therapy group demonstrated significantly lower mean total cholesterol and low-density lipoprotein cholesterol levels compared with the standard therapy group.